[go: up one dir, main page]

DK270789D0 - Hirudin-derivater, deres fremstilling og anvendelse - Google Patents

Hirudin-derivater, deres fremstilling og anvendelse

Info

Publication number
DK270789D0
DK270789D0 DK270789A DK270789A DK270789D0 DK 270789 D0 DK270789 D0 DK 270789D0 DK 270789 A DK270789 A DK 270789A DK 270789 A DK270789 A DK 270789A DK 270789 D0 DK270789 D0 DK 270789D0
Authority
DK
Denmark
Prior art keywords
preparation
hirudin derivatives
hirudin
derivatives
carrier
Prior art date
Application number
DK270789A
Other languages
English (en)
Other versions
DK270789A (da
DK175103B1 (da
Inventor
Peter Crause
Paul Habermann
Martin Kramer
Rainer Obermeier
Klaus Sauber
Dominique Tripier
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6355879&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK270789(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of DK270789D0 publication Critical patent/DK270789D0/da
Publication of DK270789A publication Critical patent/DK270789A/da
Application granted granted Critical
Publication of DK175103B1 publication Critical patent/DK175103B1/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K17/00Carrier-bound or immobilised peptides; Preparation thereof
    • C07K17/02Peptides being immobilised on, or in, an organic carrier
    • C07K17/10Peptides being immobilised on, or in, an organic carrier the carrier being a carbohydrate
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81Protease inhibitors
    • C07K14/815Protease inhibitors from leeches, e.g. hirudin, eglin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK198902707A 1988-06-04 1989-06-02 Hirudin-derivater, deres fremstilling og anvendelse DK175103B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3819079A DE3819079A1 (de) 1988-06-04 1988-06-04 Hirudin-derivate mit verzoegerter wirkung
DE3819079 1988-06-04

Publications (3)

Publication Number Publication Date
DK270789D0 true DK270789D0 (da) 1989-06-02
DK270789A DK270789A (da) 1989-12-05
DK175103B1 DK175103B1 (da) 2004-06-01

Family

ID=6355879

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198902707A DK175103B1 (da) 1988-06-04 1989-06-02 Hirudin-derivater, deres fremstilling og anvendelse

Country Status (20)

Country Link
US (1) US5538946A (da)
EP (1) EP0345616B1 (da)
JP (1) JP2804514B2 (da)
KR (1) KR0140884B1 (da)
AT (1) ATE130315T1 (da)
AU (1) AU625215B2 (da)
CA (1) CA1340197C (da)
CY (1) CY2025A (da)
DE (2) DE3819079A1 (da)
DK (1) DK175103B1 (da)
ES (1) ES2080732T3 (da)
FI (1) FI98703C (da)
GR (1) GR3018364T3 (da)
HU (1) HU204851B (da)
IE (1) IE72201B1 (da)
IL (1) IL90507A0 (da)
NO (1) NO177312C (da)
NZ (1) NZ229402A (da)
PT (1) PT90743B (da)
ZA (1) ZA894180B (da)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2000887A1 (en) * 1988-11-01 1990-05-01 Cecilia S.L. Ku Thromboresistant materials and methods for making same
JP3187044B2 (ja) * 1989-12-01 2001-07-11 ビーエーエスエフ アクチェンゲゼルシャフト ヒルジン突然変異蛋白質及びヒルジンポリアルキレングリコール複合体
JP2975632B2 (ja) * 1990-03-30 1999-11-10 生化学工業株式会社 グリコサミノグリカン修飾プロテイン
GB2247239A (en) * 1990-08-22 1992-02-26 Ciba Geigy Ag Hirudin conjugates with polyoxyethylene
DE4041185A1 (de) * 1990-12-21 1992-06-25 Knoll Ag Verwendung von hirudin und dessen muteinen zur kombinationsbehandlung von tumoren
DE4437502A1 (de) * 1993-12-02 1995-06-08 Basf Ag Hirudin-Konjugate aus Hirudin und lipophilen Verbindungen
DE4342154A1 (de) * 1993-12-10 1995-06-14 Behringwerke Ag Amidinophenylalaninderivate, Verfahren zu deren Herstellung, deren Verwendung und diese enthaltende Mittel als Antikoagulantien
DE4404168A1 (de) * 1994-02-10 1995-08-17 Hoechst Ag Hirudinderivate und Verfahren zu deren Herstellung
DE19533817C2 (de) * 1995-09-13 1999-12-09 Max Planck Gesellschaft Komplex-gebundene Hemmstoffe aktivierbarer Stoffwechselenzyme als molekulare Marker zur Diagnostik und Therapieüberwachung
US6491965B1 (en) 1995-11-30 2002-12-10 Hamilton Civic Hospitals Research Development, Inc. Medical device comprising glycosaminoglycan-antithrombin III/heparin cofactor II conjugates
US6562781B1 (en) 1995-11-30 2003-05-13 Hamilton Civic Hospitals Research Development Inc. Glycosaminoglycan-antithrombin III/heparin cofactor II conjugates
US7045585B2 (en) 1995-11-30 2006-05-16 Hamilton Civic Hospital Research Development Inc. Methods of coating a device using anti-thrombin heparin
US5856452A (en) * 1996-12-16 1999-01-05 Sembiosys Genetics Inc. Oil bodies and associated proteins as affinity matrices
DE19915862A1 (de) * 1999-04-08 2000-10-12 Max Planck Gesellschaft Verwendung von molekulargewichtserweitertem Hirudin als Antikoagulans bei der extrakorporalen Nierenersatztherapie
US6809076B2 (en) * 2000-03-20 2004-10-26 Abbott Gmbh & Co. Kg Use of anticoagulant agents in the extracorporeal treatment of blood
US6818392B2 (en) 2000-12-06 2004-11-16 Abbott Laboratories Monoclonal antibodies to human immunodeficiency virus and uses thereof

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1979000638A1 (en) * 1978-02-17 1979-09-06 Thin Conductive Coating Oester A method of producing thrombosis-resistant surfaces
DE2930542A1 (de) * 1979-07-27 1981-02-12 Hoechst Ag Neue insulinderivate und verfahren zu ihrer herstellung
ATE78294T1 (de) * 1984-03-27 1992-08-15 Transgene Sa Expressionsvektoren fuer hirudin, transformierte zellen und verfahren zur herstellung von hirudin.
US4666884A (en) * 1984-04-10 1987-05-19 New England Deaconess Hospital Method of inhibiting binding of von Willebrand factor to human platelets and inducing interaction of platelets with vessel walls
DE3438296A1 (de) * 1984-04-18 1985-11-07 Hoechst Ag, 6230 Frankfurt Neue polypeptide mit blutgerinnungshemmender wirkung, verfahren zu deren herstellung bzw. gewinnung, deren verwendung und diese enthaltende mittel
EP0168342B1 (de) * 1984-06-14 1991-07-03 Ciba-Geigy Ag Verfahren zur Herstellung von Thrombin-Inhibitoren
DE3429430A1 (de) * 1984-08-10 1986-02-20 Hoechst Ag, 6230 Frankfurt Gentechnologisches verfahren zur herstellung von hirudin und mittel zur durchfuehrung dieses verfahrens
DE3500268A1 (de) * 1985-01-05 1986-07-10 Hoechst Ag, 6230 Frankfurt Praeparate mit verzoegerter wirkung, verfahren zu deren herstellung sowie entsprechende mittel zur human- bzw. veterinaermedizinischen anwendung
DE3506992A1 (de) * 1985-02-27 1986-08-28 Plantorgan Werk Heinrich G.E. Christensen, KG, 2903 Bad Zwischenahn Modifizierte hirudine, verfahren zu deren herstellung und pharmazeutische mittel, die diese wirkstoffe enthalten
FR2593518B1 (fr) * 1985-05-02 1989-09-08 Transgene Sa Vecteurs d'expression et de secretion de l'hirudine par les levures transformees
DE3689525D1 (de) * 1985-07-17 1994-02-24 Hoechst Ag Neue Polypeptide mit blutgerinnungshemmender Wirkung, Verfahren zu deren Herstellung bzw. Gewinnung, deren Verwendung und diese enthaltende Mittel.
DE3541856A1 (de) * 1985-11-27 1987-06-04 Hoechst Ag Eukaryotische fusionsproteine, ihre herstellung und verwendung sowie mittel zur durchfuehrung des verfahrens

Also Published As

Publication number Publication date
EP0345616A3 (de) 1991-03-20
NO892267D0 (no) 1989-06-02
IL90507A0 (en) 1990-01-18
US5538946A (en) 1996-07-23
ZA894180B (en) 1990-02-28
EP0345616B1 (de) 1995-11-15
NO892267L (no) 1989-12-05
FI98703C (fi) 1997-08-11
HK1006024A1 (en) 1999-02-05
EP0345616A2 (de) 1989-12-13
HU204851B (en) 1992-02-28
ATE130315T1 (de) 1995-12-15
AU3595589A (en) 1989-12-07
NZ229402A (en) 1992-05-26
FI892686A0 (fi) 1989-06-01
JP2804514B2 (ja) 1998-09-30
AU625215B2 (en) 1992-07-02
DE3819079A1 (de) 1989-12-07
DK270789A (da) 1989-12-05
FI892686L (fi) 1989-12-05
ES2080732T3 (es) 1996-02-16
FI98703B (fi) 1997-04-30
DE58909493D1 (de) 1995-12-21
CA1340197C (en) 1998-12-15
IE72201B1 (en) 1997-04-09
IE891815L (en) 1989-12-04
PT90743A (pt) 1989-12-29
HUT51298A (en) 1990-04-28
GR3018364T3 (en) 1996-03-31
CY2025A (en) 1998-02-20
KR0140884B1 (ko) 1998-06-15
PT90743B (pt) 1994-10-31
NO177312C (no) 1995-08-23
NO177312B (no) 1995-05-15
JPH0267300A (ja) 1990-03-07
KR910001041A (ko) 1991-01-30
DK175103B1 (da) 2004-06-01

Similar Documents

Publication Publication Date Title
DK270789A (da) Hirudin-derivater, deres fremstilling og anvendelse
ATE269290T1 (de) Benzoylderivate
UA39099C2 (uk) Циклічні азотовмісні похідні, суміш їх ізомерів або окремі ізомери, або їх солі
AU8581991A (en) Mercaptoacetylamide derivatives as inhibitors of enkephalinase and ACE, and processes for their production
BR0012243A (pt) Triflúor butenos nematocidas
DK0400583T3 (da) Imidazoquinoxalinoner,deres azaanaloger og fremgangsmåde til fremstilling deraf
IL103263A0 (en) 2-substituted indane-2-mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace
NO881697D0 (no) Verktoeyenhet, verktoeydeler og fremgangsmaate for sammensetting av delene.
ATE56211T1 (de) 2-phenylbenzoxepin-derivat.
ES2063796T3 (es) Nuevos derivados de 2'-halometiliden, 2'-eteniliden- y 2'-etinil-adenosina.
NO883582D0 (no) Katodisk elektrodeponerbart belegningspreparat.
AU8032794A (en) Amidinophenylalanine derivatives, a process for their preparation, their use and compositions containing these as anticoagulants
HUT51295A (en) Process for producing peptidalcohol derivatives of anticoagulant activity
FI895844A0 (fi) Koagulation foerhindrande peptider.
BG90414A (bg) 2-азабицикло (2,2,1)-хепт-5- ен-2-оцетна киселина и нейни производни, метод за получаване и приложението им
FI891111A7 (fi) Menetelmä 1,4-dihydropyridiinijohdannaisten valmistamiseksi
IT8921657A0 (it) Procedimento per la produzione di cuoio morbido senza piombo.
NO894189D0 (no) 4-amino-3-acylkinolonderivater og deres anvendelse som inhibitorer av mavesyresekresjon.
MX9203634A (es) Derivados de pirocatecol 3,5-disubstituidos.
ATE84794T1 (de) Aminosaeure-derivate als antihypertensive.
FI935707L (fi) Anvaendning av hirudinderivat som trombininhibitorer

Legal Events

Date Code Title Description
PUP Patent expired